Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2018
Markus Müschen, M.D., Ph.D.
Targeting Lgr5-mediated self-renewal and tumor-initiation in B-cell malignancies
Read More
2018
Roger Lo, M.D., Ph.D.
Pre-Clinical and Clinical Testing of Regimented Therapies for Mutant NRAS Melanoma
Read More
2018
Justin Kline, M.D.
PD-L1 gene amplifications and the “T cell inflamed” microenvironment in DLBCL
Read More
2018
Andras Heczey, M.D.
Genomic and functional characterization of CAR T cells in children with liver...
Read More
2018
Alan Friedman, M.D.
Adoptive Transfer of NF-kB p50 Deficient Myeloid Cells as Immunotherapy for Cancer
Read More
2018
James Brugarolas, M.D., Ph.D.
Directing Immunotherapy with iPET
Read More
2018
Yanis Boumber, M.D., Ph.D.
Biomarkers of combined PD1 and VEGFR2 blockade in metastatic NSCLC
Read More
2018
Nabeel Bardeesy, Ph.D.
Refined strategies to treat FGFR-driven cholangiocarcinoma
Read More
2018
Sara St. George, Ph.D.
Formative Development and Feasibility of an Innovative Multigenerational eHealth Intervention for Overweight/Obese...
Read More
2018
Fiona Simpkins, M.D. & Eric Brown, Ph.D. & Payal Shah, M.D.
Novel PARP and ATR inhibitor combination therapies for BRCA-mutant ovarian cancer
Read More
2018
Sabine Mueller, M.D., Ph.D.
A Phase I Clinical Trial of Autologous T Cells Expressing TCR Specific...
Read More
2018
Nicola Mason, DVM, Ph.D. & Dana Clarke, VMD, DACECC
Immune targeting of the V600E B-Raf neo-antigen in canine urothelial carcinoma
Read More
2018
Hanlee Ji, M.D.
Gastric Cancer Registry
Read More
2018
Tony Huang, Ph.D.
Elucidating the Replication Fork Protection Problem Caused by PARP inhibitors in BRCA2‐mutated...
Read More
2018
Roger Greenberg, M.D., Ph.D.
Understanding and Exploiting the Heterogeneity of Cell Intrinsic and Extrinsic Responses to...
Read More
2018
Judy Garber, M.D., MPH
Development of Effective Hormonal Chemoprevention for BRCA2 Carriers
Read More